Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study

Ultra-deep sequencing of high-risk NBLs demonstrates that oncogenic aberrations are more prevalent at diagnosis than previously recognized. <i>ALK</i> and RAS pathway aberrations confer inferior outcomes in patients treated with contemporary therapy, emphasizing the need for novel therapeutic approaches.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-03-04
DOI
https://doi.org/10.1200/jco-24-02407
Citations
10
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
13.89
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study

Arlene Naranjo, Steven G. DuBois, John M. Maris, Esther R. Berko et al.
10 citations
Journal of Clinical Oncology
Neuroblastoma Research and Treatments
13.89
article

Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study

Arlene Naranjo, Steven G. DuBois, John M. Maris, Esther R. Berko, Julie R. Park, Samantha N. McNulty, Kristin Zelley, Yaël P. Mossé, Alexander A. Daniels, Balakrishna Koneru, Rochelle Bagatell, Meredith S. Irwin, Kateryna Krytska, Todd E. Druley, C. Patrick Reynolds, Lulu Chen, Grace Polkosnik
article en
10 citations

Abstract

Ultra-deep sequencing of high-risk NBLs demonstrates that oncogenic aberrations are more prevalent at diagnosis than previously recognized. <i>ALK</i> and RAS pathway aberrations confer inferior outcomes in patients treated with contemporary therapy, emphasizing the need for novel therapeutic approaches.

Journal of Clinical OncologyVol. 43(14)
Texas Tech University (US), St. Jude Children's Research Hospital (US), Children's Hospital of Philadelphia (US), Harvard University (US), Tel Aviv University (IL), University of Toronto (CA), Danaher (United States) (US), Hospital for Sick Children (CA), University of Florida (US), Schneider Children's Medical Center (IL), Children's Oncology Group (US), SickKids Foundation (CA), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US), University of Pennsylvania (US), Texas Tech University Health Sciences Center (US)
Good health and well-being
Openalex Percentile: Top 1%
Neuroblastoma Research and Treatments
13.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.